Italian Association Amici di Raoul Follereau (AIFO)

Contact

General

Project Support

Alliances & Links

Resources & Training

ARCHIVES OF LEPROSY MAILING LIST
Archives of recent messages from Leprosy Mailing List (LML) managed by Dr Salvatore Noto.

Over the past few years, LML moderated by Dr Noto has become one of the most important online resource for promoting discussions about leprosy. For joining this mailing list kindly send an email to Dr. Salvatore Noto: salvatore.notoathsanmartino.it  (substitute at with @ in the email address)

Leprosy mailing list – September 6th, 2005

Ccn:     all.

Ref.:    

“discussion document on monitoring of epidemiological trends of leprosy and validation of data”.

From:   P Saunderson, Greenville, USA.


 

 

 

Dear Dr Noto,

 

Please allow me to comment briefly on the three points you raised (S Noto LML Aug 8th, 2005) concerning the “discussion document on monitoring of epidemiological trends of leprosy and validation of data”.  The document was discussed in some detail by the ILEP Technical Commission and consensus was reached on the basis of what would be best in a practical sense in a routine, integrated setting.

 

1.

Reporting new cases per 100,000 is best because in most endemic areas this is still above 1, whereas the rate per 10,000 would now be less than 1 in many situations.  Using numbers above 1 will generally be easier for most people to follow.  Prevalence (and the prevalence/detection ratio) will very soon drop out of the discussion, so there is no need to make this link.

 

2.

For an indicator to be useful it has to be derived from as high a proportion of the total group as possible, so the classification (and thus the MB proportion) should ideally be reported for 100% of new cases.  While the skin smear is a very valuable tool, which we would all like to see used more widely, it will never be used for anything like all new cases; routine classification must be based on a simpler tool and the number of lesions works reasonably well for this purpose.  This is therefore not the right setting for a discussion on skin smears.

 

3.

Here again practical considerations should be uppermost in our minds.  It is difficult to imagine that the WHO Disability Grading could be replaced with something else which would be as widely accepted and used.  The simplicity of the current system is its strength, allowing it to be used everywhere.  I would make two further points: firstly, in at least one way, the current grading is very helpful – it is the best global indicator we have about the effectiveness of case-finding activities; while it is certainly not perfect, there is no other indicator that comes close to it in providing that information.  Secondly, the main reason for dissatisfaction with the WHO Grading is that it is thought not to be done accurately enough by most people, so that the results are not trustworthy; clearly the best approach to this would be better training and supervision, not the development of a new and more complex system, which would be even more difficult to get up and running at an acceptable level.

 

With kind regards,

 

Paul

 

Dr Paul Saunderson, MD, MRCP(UK)

Leprosy Consultant,

American Leprosy Missions,

1 ALM Way, Greenville, SC 29601, USA

Phone: +1 864 241 1750

Email: psaunderson@leprosy.org

Web: www.leprosy.org

 

<< BACK TO LML ARCHIVE INDEX

 

AIFO, Via Borselli 4-6, 40135 Bologna, Italy
Tel: +390-51-4393.211 Fax: +390-51-434046 Email: info@aifo.it